Allergy Therapeutics
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Acarovac Plus, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom. Show More...
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 7.10 GBX
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share GBP -0.010 -0.02 -0.010 0.010 0.010 Dividends GBP Payout Ratio % * Shares Mil 306.0 323.0 340.0 472.0 472.0 498.0 570.0 592.0 625.0 670.0 672.0 Book Value Per Share * GBP 0.010 0.010 0.03 0.05 0.05 0.04 0.08 0.06 0.06 0.07 0.08 Free Cash Flow Per Share * GBP -0.010 0.010 0.010 -0.010 -0.02 -0.010 Return on Assets % 2.29 -8.91 2.82 1.89 2.58 0.27 -24.35 -4.36 -13.92 5.8 10.58 Financial Leverage (Average) 7.49 14.32 1.9 1.97 1.88 1.47 1.87 1.91 2.21 1.82 1.72 Return on Equity % -88.37 9.84 3.66 4.98 0.44 -40.35 -8.23 -28.43 11.44 17.6 Return on Invested Capital % -9.27 12.74 5.56 5.85 0.76 -37.08 -7.19 -24.88 10.77 15.79 Interest Coverage 0.94 -0.5 1.47 2.07 4.52 4.0 -40.17 -7.76 -20.55 22.36 26.58 Current Ratio 1.48 1.34 1.68 1.9 2.2 4.55 3.0 2.67 2.11 2.77 3.83 Quick Ratio 0.72 0.61 0.76 0.86 1.12 3.52 2.36 2.11 1.47 2.17 3.23 Debt/Equity 2.73 5.78 0.010 0.04 0.1 0.1 0.1 0.05 0.17